Use and adherence to beta-blockers for secondary prevention of myocardial infarction: who is not getting the treatment?
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Epidemiology
Reference29 articles.
1. beta Blockade after myocardial infarction: systematic review and meta regression analysis
2. Current utilization trends for β-blockers in cardiovascular disease
3. Which drugs benefit diabetic patients for secondary prevention of myocardial infarction?
4. Effect of Beta-Blockade on Mortality among High-Risk and Low-Risk Patients after Myocardial Infarction
5. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Description of patient questions received by clinical pharmacists in the Nudge Study;American Journal of Health-System Pharmacy;2023-06-23
2. Beta-blockers in post-acute myocardial infarction patients: Drug prescription patterns from 2018 to Italy’s first wave of the COVID-19 pandemic;Frontiers in Pharmacology;2022-12-07
3. Adherence with cardiovascular medications and the outcomes in patients with coronary arterial disease: “Real‐world” evidence;Clinical Cardiology;2022-09-18
4. The NUDGE trial pragmatic trial to enhance cardiovascular medication adherence: study protocol for a randomized controlled trial;Trials;2021-08-11
5. Adherence to antihypertensive medications for secondary prevention of cardiovascular disease events: a dose-response meta-analysis;Public Health;2021-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3